WATERFORD, Ireland, Sept. 2021 /PRNewswire/ — TriviumVet™, an animal health research and development company focused on addressing unmet needs in companion animal medicine, today announced that the Food and Drug Administration’s Centre for Veterinary Medicine has determined that the company can pursue the expanded conditional approval pathway for its feline hypertrophic cardiomyopathy (HCM) therapeutic candidate, [...]